Abstract
The objective of present investigation was the characterization of chitosan films after in vivo implantation. Chitosan films were prepared at three dose loadings of paclitaxel by classical casting method. They were implanted subcutaneously in Swiss mice in the neck region and were removed at 7, 15, 21 and 30 days post implantation for characterization. In vitro release studies on explanted films were done to observe the influence of the time of implantation and loading on paclitaxel release, which were correlated with amount of paclitaxel remaining in films. Residual amount of paclitaxel remaining in explanted films decreased with increase in loading i.e. after 30 days, the % residual content of drug at 25, 20 and 15 mg loadings (per film) were 13, 20 and 45% of the initial loading. The in vivo release of paclitaxel from films with higher loadings was higher, indicating that paclitaxel, per se, altered biodegradation of chitosan. Light microscopy and SEM studies of films removed from mice provided qualitative information on the loss of integrity and biodegradation of films with time. Further, FTIR and ATR-FTIR spectra revealed the changes in the film matrix that occur after implantation.
Keywords: Chitosan film, paclitaxel, FTIR, drug release
Current Drug Delivery
Title: An Ex Vivo Characterization of Paclitaxel Loaded Chitosan Films After Implantation in Mice
Volume: 3 Issue: 3
Author(s): Ramesh Panchagnula, Renu Singh Dhanikula and Anand Babu Dhanikula
Affiliation:
Keywords: Chitosan film, paclitaxel, FTIR, drug release
Abstract: The objective of present investigation was the characterization of chitosan films after in vivo implantation. Chitosan films were prepared at three dose loadings of paclitaxel by classical casting method. They were implanted subcutaneously in Swiss mice in the neck region and were removed at 7, 15, 21 and 30 days post implantation for characterization. In vitro release studies on explanted films were done to observe the influence of the time of implantation and loading on paclitaxel release, which were correlated with amount of paclitaxel remaining in films. Residual amount of paclitaxel remaining in explanted films decreased with increase in loading i.e. after 30 days, the % residual content of drug at 25, 20 and 15 mg loadings (per film) were 13, 20 and 45% of the initial loading. The in vivo release of paclitaxel from films with higher loadings was higher, indicating that paclitaxel, per se, altered biodegradation of chitosan. Light microscopy and SEM studies of films removed from mice provided qualitative information on the loss of integrity and biodegradation of films with time. Further, FTIR and ATR-FTIR spectra revealed the changes in the film matrix that occur after implantation.
Export Options
About this article
Cite this article as:
Panchagnula Ramesh, Singh Dhanikula Renu and Babu Dhanikula Anand, An Ex Vivo Characterization of Paclitaxel Loaded Chitosan Films After Implantation in Mice, Current Drug Delivery 2006; 3 (3) . https://dx.doi.org/10.2174/156720106777731028
DOI https://dx.doi.org/10.2174/156720106777731028 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Extracellular vesicles as drug delivery systems
Extracellular vesicles (EVs) are membranous vesicles released from almost all types of cells into extracellular space. EVs are categorized into different types including exosome (~30-150 nm), microvesicle or microparticle (~100-1,000 nm), apoptotic body (~1,000-5,000 nm), and others produced by different mechanisms. Since EVs bear the molecules (e.g., specific lipids, carbohydrates, ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers